GSK-3/CREB pathway involved in the gx-50's effect on Alzheimer's disease

Neuropharmacology

Volumn 81, Issue , 2014, Pages 256-266

  Tang, Maoping ^a   Shi, Shi ^a   Guo, Yubing ^a   Xu, Wangjie ^a   Wang, Lianyun ^a   Chen, Yi ^a   Wang, Zhaoxia ^a   Qiao, Zhongdong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Alzheimer's disease; cAMP response element binding protein; Glycogen synthase kinase 3; gx 50; Microarray analysis

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GX 50; N [2 (3, 4 DIMETHOXYPHENYL)ETHYL] 3 PHENYL ACRYLAMIDE; NEUROPROTECTIVE AGENT; OLIGOMER; PROTEIN KINASE B; UNCLASSIFIED DRUG; ACRYLAMIDE DERIVATIVE; AMYLOID PRECURSOR PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; N-(2-(3,4-DIMETHOXYPHENYL)ETHYL)-3-PHENYL-ACRYLAMIDE; NERVE PROTEIN; NEUROLEPTIC AGENT;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOACCUMULATION; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE CONTROL; GENE EXPRESSION; GENE ONTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; ANIMAL; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT;

ACRYLAMIDES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANIMALS, NEWBORN; ANTIPSYCHOTIC AGENTS; CELLS, CULTURED; CREB-BINDING PROTEIN; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84896131461     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.02.008     Document Type: Article

References (57)

1. T. Abbas, E. Faivre, and C. Hölscher Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: interaction between type 2 diabetes and Alzheimer's disease Behav. Brain Res. 205 2009 265 271
2. L. Bertram, and R.E. Tanzi Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses Nat. Rev. Neurosci. 9 2008 768 778
3. R.S. Bitner Cyclic AMP response element-binding protein (CREB) phosphorylation: a mechanistic marker in the development of memory enhancing Alzheimer's disease therapeutics Biochem. Pharmacol. 83 2012 705 714
4. R. Brookmeyer, E. Johnson, K. Ziegler-Graham, and H.M. Arrighi Forecasting the global burden of Alzheimer's disease Alzheimers Dement. 3 2007 186 191 (Pubitemid 46825511)
5. P.O. Brown, and D. Botstein Exploring the new world of the genome with DNA microarrays Nat. Genet. 21 1999 33 37 (Pubitemid 29031489)
6. M. Bućan, and T. Abel The mouse: genetics meets behaviour Nat. Rev. Genet. 3 2002 114 123 (Pubitemid 34506595)
7. D.A.E. Cross, D.R. Alessi, P. Cohen, M. Andjelkovich, and B.A. Hemmings Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378 1995 785 789 (Pubitemid 26004411)
8. F.H. Cruzalegui, and H. Bading Calcium-regulated protein kinase cascades and their transcription factor targets Cell. Mol. Life Sci. 57 2000 402 410 (Pubitemid 30223567)
9. B. DaRocha-Souto, M. Coma, B.G. Pérez-Nievas, T.C. Scotton, M. Siao, and P. Sánchez-Ferrer et al. Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease Neurobiol. Dis. 45 2012 425 437
10. J. De Faria Poloni, B.C. Feltes, and D. Bonatto Melatonin as a central molecule connecting neural development and calcium signaling Funct. Integr. Genomics 11 2011 383 388
11. G.V. De Ferrari, and N.C. Inestrosa Wnt signaling function in Alzheimer's disease Brain Res. Rev. 33 2000 1 12
12. B. De Strooper Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process Physiol. Rev. 90 2010 465 494
13. K. Deisseroth, H. Bito, and R.W. Tsien Signaling from synapse to nucleus: postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity Neuron 16 1996 89 101 (Pubitemid 26044732)
14. L.A. Denner, J. Rodriguez-Rivera, S.J. Haidacher, J.B. Jahrling, J.R. Carmical, and C.M. Hernandez et al. Cognitive enhancement with rosiglitazone links the hippocampal PPARγ and ERK MAPK signaling pathways J. Neurosci. 32 2012 16725 16735
15. S.G.N. Grant, T.J. O'Dell, K.A. Karl, P.L. Stein, P. Soriano, and E.R. Kandel Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice Science 258 1992 1903 1910 (Pubitemid 23026728)
16. D. Harold, R. Abraham, P. Hollingworth, R. Sims, A. Gerrish, and M.L. Hamshere et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nat. Genet. 41 2009 1088 1093
17. R. Hashimoto, V. Senatorov, H. Kanai, P. Leeds, and D.M. Chuang Lithium stimulates progenitor proliferation in cultured brain neurons Neuroscience 117 2003 55 61 (Pubitemid 36246503)
18. R. Hepp, L. Tricoire, E. Hu, N. Gervasi, D. Paupardin-Tritsch, and B. Lambolez et al. Phosphodiesterase type 2 and the homeostasis of cyclic GMP in living thalamic neurons J. Neurochem. 102 2007 1875 1886 (Pubitemid 47329259)
19. F. Hernández, J. Borrell, C. Guaza, J. Avila, and J.J. Lucas Spatial learning deficit in transgenic mice that conditionally over-express GSK-3β in the brain but do not form tau filaments J. Neurochem. 83 2002 1529 1533 (Pubitemid 35477491)
20. C. Hooper, V. Markevich, F. Plattner, R. Killick, E. Schofield, and T. Engel et al. Glycogen synthase kinase-3 inhibition is integral to long-term potentiation Eur. J. Neurosci. 25 2007 81 86 (Pubitemid 46096224)
21. E.M. Hur, and F.Q. Zhou GSK3 signalling in neural development Nat. Rev. Neurosci. 11 2010 539 551
22. K. Irie, K. Murakami, Y. Masuda, A. Morimoto, H. Ohigashi, and H. Hara et al. The toxic conformation of the 42-residue amyloid β peptide and its relevance to oxidative stress in Alzheimer's disease Mini Rev. Med. Chem. 7 2007 1001 1008 (Pubitemid 47554768)
23. J.L. Jankowsky, H.H. Slunt, V. Gonzales, A.V. Savonenko, J.C. Wen, and N.A. Jenkins et al. Persistent amyloidosis following suppression of Aβ production in a transgenic model of Alzheimer disease PLoS Med. 2 2005 1318 1333 (Pubitemid 43020991)
24. S. Jimenez, M. Torres, M. Vizuete, R. Sanchez-Varo, E. Sanchez-Mejias, and L. Trujillo-Estrada et al. Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)/Akt-GSK-3beta pathway in Alzheimer mouse model J. Biol. Chem. 286 2011 18414 18425
25. L. Keller, H. Welander, H.H. Chiang, L.O. Tjernberg, I. Nennesmo, and A.K. Wallin et al. The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of Aβ in different brain regions Eur. J. Hum. Genet. 18 2010 1202 1208
26. M. Konrad, M. Vollmer, H.H. Lemmink, L.P.W.J. Van Den Heuvel, N. Jeck, and R. Vargas-Poussou et al. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome J. Am. Soc. Nephrol. 11 2000 1449 1459 (Pubitemid 30483461)
27. S.D. Kuipers, and C.R. Bramham Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy Curr. Opin. Drug Disc. Dev. 9 2006 580 586 (Pubitemid 44378826)
28. H.K. Lee, A.K. Hsu, J. Sajdak, J. Qin, and P. Pavlidis Coexpression analysis of human genes across many microarray data sets Genome Res. 14 2004 1085 1094 (Pubitemid 38811545)
29. K. Leroy, and J.P. Brion Developmental expression and localization of glycogen synthase kinase-3β in rat brain J. Chem. Neuroanat. 16 1999 279 293 (Pubitemid 29296952)
30. J.R. Levin, G. Serrano, and R. Dingledine Reduction in delayed mortality and subtle improvement in retrograde memory performance in pilocarpine-treated mice with conditional neuronal deletion of cyclooxygenase-2 gene Epilepsia 53 2012 1411 1420
31. B.E. Lonze, and D.D. Ginty Function and regulation of CREB family transcription factors in the nervous system Neuron 35 2002 605 623 (Pubitemid 35229980)
32. B. Lu, G. Nagappan, X. Guan, P.J. Nathan, and P. Wren BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases Nat. Rev. Neurosci. 14 2013 401 416
33. Q.H. Ma, T. Futagawa, W.L. Yang, X.D. Jiang, L. Zeng, and Y. Takeda et al. A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis Nat. Cell Biol. 10 2008 283 294 (Pubitemid 351331015)
34. A. Martinez, A. Castro, M. Medina, and B.H. Wang Glycogen Synthase Kinase 3 (GSK-3) and its Inhibitors - Drug Discovery and Development first ed. 2006 John Wiley & Sons Inc
35. C.T. Mendes, F.B. Mury, E. De Sá Moreira, F.L. Alberto, O.V. Forlenza, and E. Dias-Neto et al. Lithium reduces Gsk3b mRNA levels: implications for Alzheimer disease Eur. Arch. Psychiatry Clin. Neurosci. 259 2009 16 22
36. B.D. Moyer, P. Hevezi, N. Gao, M. Lu, D. Kalabat, and H. Soto et al. Expression of genes encoding multi-transmembrane proteins in specific primate taste cell populations PLoS One 4 2009 art. no. e7682
37. S. Mruthinti, N. Capito, A. Sood, and J.J. Buccafusco Cytotoxicity of Aβ1-42, RAGE23-54, and an Aβ-RAGE complex in PC-12 cells Curr. Alzheimer Res. 4 2007 581 586 (Pubitemid 350248397)
38. A. Orlacchio, T. Kawarai, M. Polidoro, A. Stefani, P.H. St George-Hyslop, and G. Bernardi Association analysis between Alzheimer's disease and the Nicastrin gene polymorphisms Neurosci. Lett. 333 2002 115 118 (Pubitemid 35284898)
39. S. Peineau, C. Taghibiglou, C. Bradley, T.P. Wong, L. Liu, and J. Lu et al. LTP inhibits LTD in the Hippocampus via regulation of GSK3β Neuron 53 2007 703 717 (Pubitemid 46283369)
40. S.G. Potkin, G. Guffanti, A. Lakatos, J.A. Turner, F. Kruggel, and J.H. Fallon et al. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's Disease PLoS One 4 2009 e6501
41. R.Q. Quiroga, L. Reddy, G. Kreiman, C. Koch, and I. Fried Invariant visual representation by single neurons in the human brain Nature 435 2005 1102 1107 (Pubitemid 40910517)
42. E. Rockenstein, K. Ubhi, E. Pham, S. Michael, E. Doppler, and P. Novak et al. Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease J. Neurosci. Res. 89 2011 1812 1821
43. C.A. Sandman, P.D. Wadhwa, A. Chicz-DeMet, M. Porto, and T.J. Garite Maternal corticotropin-releasing hormone and habituation in the human fetus Dev. Psychobiol. 34 1999 163 173 (Pubitemid 29165944)
44. M. Schena, D. Shalon, R.W. Davis, and P.O. Brown Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 270 1995 467 470
45. M.J. Sekeres, R.L. Neve, P.W. Frankland, and S.A. Josselyn Dorsal hippocampal CREB is both necessary and sufficient for spatial memory Learn. Mem. 17 2005 280 283
46. Q. Shi, L. Guo, T.A. Patterson, S. Dial, Q. Li, and N. Sadovova et al. Gene expression profiling in the developing rat brain exposed to ketamine Neuroscience 166 2010 852 863
47. W.J. Strittmatter Old drug, new hope for Alzheimer's disease Science 335 2012 1447 1448
48. M. Tang, Z.X. Wang, Y. Zhou, W. Xu, S. Li, and L. Wang et al. A novel drug candidate for Alzheimer's disease treatment: gx-50 derived from Zanthoxylum Bungeanum J. Alzheimers Dis. 34 2013 203 213
49. A. Trentani, S.D. Kuipers, G.J. Ter Horst, and J.A. Den Boer Selective chronic stress-induced in vivo ERK1/2 hyperphosphorylation in medial prefrontocortical dendrites: implications for stress-related cortical pathology? Eur. J. Neurosci. 15 2002 1681 1691 (Pubitemid 35471924)
50. S.C. Upadhya, T.K. Smith, P.A. Brennan, J.C. Mychaleckyj, and A.N. Hegde Expression profiling reveals differential gene induction underlying specific and non-specific memory for pheromones in mice Neurochem. Int. 59 2011 787 803
51. L. Verret, J.L. Jankowsky, G.M. Xu, D.R. Borchelt, and C. Rampon Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis J. Neurosci. 27 2007 6771 6780 (Pubitemid 46983445)
52. M.R. Wilson, J.J. Yerbury, and S. Poon Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity Mol. Biosyst. 4 2007 42 52 (Pubitemid 350261753)
53. H.N. Woo, J.S. Park, A.R. Gwon, T.V. Arumugam, and D.G. Jo Alzheimer's disease and Notch signaling Biochem. Biophys. Res. Commun. 390 2009 1093 1097
54. X. Xu, M. Zhan, W. Duan, V. Prabhu, R. Brenneman, and W. Wood et al. Gene expression atlas of the mouse central nervous system: impact and interactions of age, energy intake and gender Genome Biol. 8 2007 R234
55. G.S.H. Yeo, C.C.C. Hung, J. Rochford, J. Keogh, J. Gray, and S. Sivaramakrishnan et al. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay Nat. Neurosci. 7 2004 1187 1189 (Pubitemid 39426236)
56. H. Zeng, Q. Chen, and B. Zhao Genistein ameliorates β-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis Free Radic. Biol. Med. 36 2004 180 188 (Pubitemid 38117236)
57. X. Zhu, C.A. Rottkamp, A.K. Raina, G.J. Brewer, H.A. Ghanbari, and H. Boux et al. Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease Neurobiol. Aging 21 2000 807 813